世界の女性健康診断市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)

GlobalInfoResearchが発行した調査報告書(GIR21JY00001)
◆英語タイトル:Global Women Health Diagnostics Market 2021 by Company, Regions, Type and Application, Forecast to 2026
◆商品コード:GIR21JY00001
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2021年7月(※2024年版があります。お問い合わせください。)
◆ページ数:90
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2~3日)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

GlobalInfoResearch社の本調査レポートでは、女性健康診断の世界市場を広く調査・分析し、今後の市場展望をまとめております。女性健康診断の種類別市場規模(出生前検査、ダウン症、HPV、出生前検査、妊娠検査、その他)、用途別市場規模(病院、在宅ケア)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):Agilent Technologies, Inc.、Ariosa Diagnostics, Inc、Bio-Rad Laboratories, Inc、Illumina, Inc、Laboratory Corporation of America Holdings、Natera, Inc、PerkinElmer, Inc、Sequenom, Inc、LifeCodexx、Cenata、Berrygenomics、BGI
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:出生前検査、ダウン症、HPV、出生前検査、妊娠検査、その他
・用途別分析2016年-2026年:病院、在宅ケア
・女性健康診断の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・女性健康診断のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・女性健康診断のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・女性健康診断の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・女性健康診断の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
【レポートの概要】

The Women Health Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Women Health Diagnostics size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Women Health Diagnostics market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Women Health Diagnostics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Prenatal Testing
Down Syndrome
HPV
Fertility Test
Pregnancy Test
Other

Market segment by Application, can be divided into
Hospitals
Home Care

Market segment by players, this report covers
Agilent Technologies, Inc.
Ariosa Diagnostics, Inc
Bio-Rad Laboratories, Inc
Illumina, Inc
Laboratory Corporation of America Holdings
Natera, Inc
PerkinElmer, Inc
Sequenom, Inc
LifeCodexx
Cenata
Berrygenomics
BGI

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Women Health Diagnostics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Women Health Diagnostics, with revenue, gross margin and global market share of Women Health Diagnostics from 2019 to 2021.
Chapter 3, the Women Health Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Women Health Diagnostics market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Women Health Diagnostics research findings and conclusion, appendix and data source.

【レポートの目次】

1 Market Overview
1.1 Product Overview and Scope of Women Health Diagnostics
1.2 Classification of Women Health Diagnostics by Type
1.2.1 Overview: Global Women Health Diagnostics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Women Health Diagnostics Revenue Market Share by Type in 2020
1.2.3 Prenatal Testing
1.2.4 Down Syndrome
1.2.5 HPV
1.2.6 Fertility Test
1.2.7 Pregnancy Test
1.2.8 Other
1.3 Global Women Health Diagnostics Market by Application
1.3.1 Overview: Global Women Health Diagnostics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Home Care
1.4 Global Women Health Diagnostics Market Size & Forecast
1.5 Global Women Health Diagnostics Market Size and Forecast by Region
1.5.1 Global Women Health Diagnostics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Women Health Diagnostics Market Size by Region, (2016-2021)
1.5.3 North America Women Health Diagnostics Market Size and Prospect (2016-2026)
1.5.4 Europe Women Health Diagnostics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Women Health Diagnostics Market Size and Prospect (2016-2026)
1.5.6 South America Women Health Diagnostics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Women Health Diagnostics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Women Health Diagnostics Market Drivers
1.6.2 Women Health Diagnostics Market Restraints
1.6.3 Women Health Diagnostics Trends Analysis
2 Company Profiles
2.1 Agilent Technologies, Inc.
2.1.1 Agilent Technologies, Inc. Details
2.1.2 Agilent Technologies, Inc. Major Business
2.1.3 Agilent Technologies, Inc. Women Health Diagnostics Product and Solutions
2.1.4 Agilent Technologies, Inc. Women Health Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Agilent Technologies, Inc. Recent Developments and Future Plans
2.2 Ariosa Diagnostics, Inc
2.2.1 Ariosa Diagnostics, Inc Details
2.2.2 Ariosa Diagnostics, Inc Major Business
2.2.3 Ariosa Diagnostics, Inc Women Health Diagnostics Product and Solutions
2.2.4 Ariosa Diagnostics, Inc Women Health Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Ariosa Diagnostics, Inc Recent Developments and Future Plans
2.3 Bio-Rad Laboratories, Inc
2.3.1 Bio-Rad Laboratories, Inc Details
2.3.2 Bio-Rad Laboratories, Inc Major Business
2.3.3 Bio-Rad Laboratories, Inc Women Health Diagnostics Product and Solutions
2.3.4 Bio-Rad Laboratories, Inc Women Health Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Bio-Rad Laboratories, Inc Recent Developments and Future Plans
2.4 Illumina, Inc
2.4.1 Illumina, Inc Details
2.4.2 Illumina, Inc Major Business
2.4.3 Illumina, Inc Women Health Diagnostics Product and Solutions
2.4.4 Illumina, Inc Women Health Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Illumina, Inc Recent Developments and Future Plans
2.5 Laboratory Corporation of America Holdings
2.5.1 Laboratory Corporation of America Holdings Details
2.5.2 Laboratory Corporation of America Holdings Major Business
2.5.3 Laboratory Corporation of America Holdings Women Health Diagnostics Product and Solutions
2.5.4 Laboratory Corporation of America Holdings Women Health Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Laboratory Corporation of America Holdings Recent Developments and Future Plans
2.6 Natera, Inc
2.6.1 Natera, Inc Details
2.6.2 Natera, Inc Major Business
2.6.3 Natera, Inc Women Health Diagnostics Product and Solutions
2.6.4 Natera, Inc Women Health Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Natera, Inc Recent Developments and Future Plans
2.7 PerkinElmer, Inc
2.7.1 PerkinElmer, Inc Details
2.7.2 PerkinElmer, Inc Major Business
2.7.3 PerkinElmer, Inc Women Health Diagnostics Product and Solutions
2.7.4 PerkinElmer, Inc Women Health Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 PerkinElmer, Inc Recent Developments and Future Plans
2.8 Sequenom, Inc
2.8.1 Sequenom, Inc Details
2.8.2 Sequenom, Inc Major Business
2.8.3 Sequenom, Inc Women Health Diagnostics Product and Solutions
2.8.4 Sequenom, Inc Women Health Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Sequenom, Inc Recent Developments and Future Plans
2.9 LifeCodexx
2.9.1 LifeCodexx Details
2.9.2 LifeCodexx Major Business
2.9.3 LifeCodexx Women Health Diagnostics Product and Solutions
2.9.4 LifeCodexx Women Health Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 LifeCodexx Recent Developments and Future Plans
2.10 Cenata
2.10.1 Cenata Details
2.10.2 Cenata Major Business
2.10.3 Cenata Women Health Diagnostics Product and Solutions
2.10.4 Cenata Women Health Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Cenata Recent Developments and Future Plans
2.11 Berrygenomics
2.11.1 Berrygenomics Details
2.11.2 Berrygenomics Major Business
2.11.3 Berrygenomics Women Health Diagnostics Product and Solutions
2.11.4 Berrygenomics Women Health Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Berrygenomics Recent Developments and Future Plans
2.12 BGI
2.12.1 BGI Details
2.12.2 BGI Major Business
2.12.3 BGI Women Health Diagnostics Product and Solutions
2.12.4 BGI Women Health Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 BGI Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Women Health Diagnostics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Women Health Diagnostics Players Market Share
3.2.2 Top 10 Women Health Diagnostics Players Market Share
3.2.3 Market Competition Trend
3.3 Women Health Diagnostics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Women Health Diagnostics Revenue and Market Share by Type (2016-2021)
4.2 Global Women Health Diagnostics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Women Health Diagnostics Revenue Market Share by Application (2016-2021)
5.2 Women Health Diagnostics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Women Health Diagnostics Revenue by Type (2016-2026)
6.2 North America Women Health Diagnostics Revenue by Application (2016-2026)
6.3 North America Women Health Diagnostics Market Size by Country
6.3.1 North America Women Health Diagnostics Revenue by Country (2016-2026)
6.3.2 United States Women Health Diagnostics Market Size and Forecast (2016-2026)
6.3.3 Canada Women Health Diagnostics Market Size and Forecast (2016-2026)
6.3.4 Mexico Women Health Diagnostics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Women Health Diagnostics Revenue by Type (2016-2026)
7.2 Europe Women Health Diagnostics Revenue by Application (2016-2026)
7.3 Europe Women Health Diagnostics Market Size by Country
7.3.1 Europe Women Health Diagnostics Revenue by Country (2016-2026)
7.3.2 Germany Women Health Diagnostics Market Size and Forecast (2016-2026)
7.3.3 France Women Health Diagnostics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Women Health Diagnostics Market Size and Forecast (2016-2026)
7.3.5 Russia Women Health Diagnostics Market Size and Forecast (2016-2026)
7.3.6 Italy Women Health Diagnostics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Women Health Diagnostics Revenue by Type (2016-2026)
8.2 Asia-Pacific Women Health Diagnostics Revenue by Application (2016-2026)
8.3 Asia-Pacific Women Health Diagnostics Market Size by Region
8.3.1 Asia-Pacific Women Health Diagnostics Revenue by Region (2016-2026)
8.3.2 China Women Health Diagnostics Market Size and Forecast (2016-2026)
8.3.3 Japan Women Health Diagnostics Market Size and Forecast (2016-2026)
8.3.4 South Korea Women Health Diagnostics Market Size and Forecast (2016-2026)
8.3.5 India Women Health Diagnostics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Women Health Diagnostics Market Size and Forecast (2016-2026)
8.3.7 Australia Women Health Diagnostics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Women Health Diagnostics Revenue by Type (2016-2026)
9.2 South America Women Health Diagnostics Revenue by Application (2016-2026)
9.3 South America Women Health Diagnostics Market Size by Country
9.3.1 South America Women Health Diagnostics Revenue by Country (2016-2026)
9.3.2 Brazil Women Health Diagnostics Market Size and Forecast (2016-2026)
9.3.3 Argentina Women Health Diagnostics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Women Health Diagnostics Revenue by Type (2016-2026)
10.2 Middle East & Africa Women Health Diagnostics Revenue by Application (2016-2026)
10.3 Middle East & Africa Women Health Diagnostics Market Size by Country
10.3.1 Middle East & Africa Women Health Diagnostics Revenue by Country (2016-2026)
10.3.2 Turkey Women Health Diagnostics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Women Health Diagnostics Market Size and Forecast (2016-2026)
10.3.4 UAE Women Health Diagnostics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

...

【掲載企業】

Agilent Technologies, Inc.、Ariosa Diagnostics, Inc、Bio-Rad Laboratories, Inc、Illumina, Inc、Laboratory Corporation of America Holdings、Natera, Inc、PerkinElmer, Inc、Sequenom, Inc、LifeCodexx、Cenata、Berrygenomics、BGI

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の女性健康診断市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)(Global Women Health Diagnostics Market 2021 by Company, Regions, Type and Application, Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。